Mason V. Hargett Papers 1932-1986 (bulk 1938-1946)

ArchivalResource

Mason V. Hargett Papers 1932-1986 (bulk 1938-1946)

Mason V. Hargett contributed greatly to the field of tropical medicine with his work on the yellow fever vaccine, first with the Rockefeller Foundation in Brazil and then at the USPHS Rocky Mountain Laboratory in Montana. Hargett's research facilitated the introduction of a yellow fever vaccine produced without human serum.

eng,

Information

SNAC Resource ID: 6387802

Related Entities

There are 5 Entities related to this resource.

Burruss, Harry W.

http://n2t.net/ark:/99166/w63d1wbh (person)

Hargett, Mason V.

http://n2t.net/ark:/99166/w6t029cp (person)

Mason V. Hargett contributed greatly to the field of tropical medicine with his work on the yellow fever vaccine, first with the Rockefeller Foundation in Brazil and then at the USPHS Rocky Mountain Laboratory in Montana. Hargett's research facilitated the introduction of a yellow fever vaccine produced without human serum, thereby reducing the possibility of contamination that had existed before. Hargett designed, as well as headed, the Yellow Fever Unit at the Rocky Mountain Labor...

Rockefeller Foundation. International Health Division

http://n2t.net/ark:/99166/w6v44p0r (corporateBody)

Rocky Mountain Laboratory

http://n2t.net/ark:/99166/w6743mpx (corporateBody)

United States. Public Health Service

http://n2t.net/ark:/99166/w65x64pk (corporateBody)

In April 1955 the Department of HEW licensed 6 companies to distribute a newly-developed polio vaccine developed by Jonas Salk of the National Foundation for Infantile Paralysis. The vaccine's effectiveness had been endorsed by NIH and the Surgeon General. Shortly after the vaccine was distributed, however, Cutter laboratory's allotment was found to be tainted and a cause of 72 new cases of polio. Responding to the crisis, the U.S. Public Health Service directed CDC epidemiologist Alexander Lang...